Fate Therapeutics Inc FATE:NASDAQ

Last Price$18.69Cboe Real-Time Last Sale as of 3:04PM ET 8/20/19
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.30(1.58%)
Bid (Size)$18.66 (200)
Ask (Size)$18.70 (200)
Day Low / High$18.50 - 19.02
Volume263.4 K

Insider Trends: Insider 90-Day Selling Trend Extended at Fate Therapeutics

5:11PM ET 2/01/2019 MT Newswires
Dr Amir Nashat, Director, sold 53,017 shares in Fate Therapeutics (FATE) for $750,959 on Jan 30, 2019. Dr Nashat, following the transactions outlined in the Form 4 SEC filing, has indirect ownership of 1,473,186 shares of the company, with a market value, based on the prior-day closing price, of $22.3 million.

Over the last 90 days, prior to the date of this filing, there have been 15 insider transactions reported to the SEC for Fate Therapeutics. These transactions came from the activities of 5 separate insiders that resulted in a net disposition of 561,983 company shares. In the preceding 90-day window of time, there was 1 transaction from 1 insider that culminated in the acquisition of 3,703,704 shares.

This is lower than the average level of insider transactions in the 324-company Bio Therapeutic Drugs peer group over the last 90-day period. Activity in the peer group averaged 29.5 transactions per company, with company insiders acquiring on average 13,634 shares.

SEC Story Link http://www.sec.gov/Archives/edgar/data/1434316/000089924319002335/xslF345X03/doc4.xml